Cagrilintide Protocol
Dosing & Research
Last Updated: April 22, 2026
Weight-loss studies, Appetite regulation, Amylin signaling, Combination obesity pharmacology
Half-Life
Continuous Treatment Recommended
Administration
some studies up to 4.5mg)
Frequency
Injection (subcutaneous)
How It Works
- Long-acting
- approximately 1 week supports once-weekly dosing
- Weight-loss studies
- Appetite regulation
- Amylin signaling
Dosing Structure
Dose
250–500 mcg 3x weekly
Frequency
Injection (subcutaneous)
Example Protocols
Dose: 250–500 mcg 3x weekly
Frequency: Injection (subcutaneous)
Duration: 8-12 weeks
Off Period: Not listed
Research & Studies
Loading citations…
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Be the first to submit research feedback for this peptide.
Approved submissions will appear here as aggregated insights.